Latest Allogeneic stem cell transplantation Stories
AMSTERDAM, November 30 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today that the first patients have been enrolled in its multinational registration clinical trial with ATIR(TM).
SANTA MONICA, Calif., April 30 /PRNewswire-FirstCall/ -- Cord Blood America, Inc.
HACKENSACK, N.J., July 16 /PRNewswire/ -- Over the past two decades, stem cell transplantation has evolved from being an experimental treatment to one that is a viable option for patients with hematologic (blood) malignancies and other life-threatening blood disorders.
- A serpent whose bite was fabled to produce intense thirst.